Our Response to COVID-19
Our Global Response
As new variants of SARS-CoV-2 arise, the global response must change and adapt. Tracking the infection and our immune response towards it becomes increasingly important.
Quansys Biosciences has recently introduced the new Q-Plex™ Human SARS-CoV-2 IgG (5-Plex) which detects antibodies specific for the nucleocapsid in addition to the spike glycoproteins S1 and S2. This allows researchers to distinguish between antibodies gained through vaccination and those that arose against a natural infection.
The new Q-Plex™ Human SARS-CoV-2 IgG (5-Plex) is one of several assays offered by Quansys Biosciences to support research on SARS-CoV-2. As vaccinations against SARS-CoV-2 become more prevalent worldwide many look forward to a return to normalcy.